Cargando…

Leucine and Glutamic Acid as a Biomarker of Sarcopenic Risk in Japanese People with Type 2 Diabetes

This study aimed to identify the serum metabolites associated with sarcopenic risk in Japanese patients with type 2 diabetes, determine the effect of dietary protein intake on the serum metabolic profile, and examine its association with sarcopenia. Ninety-nine Japanese patients with type 2 diabetes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakajima, Hanako, Okada, Hiroshi, Kobayashi, Ayaka, Takahashi, Fuyuko, Okamura, Takuro, Hashimoto, Yoshitaka, Nakanishi, Naoko, Senmaru, Takafumi, Ushigome, Emi, Hamaguchi, Masahide, Fukui, Michiaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222500/ https://www.ncbi.nlm.nih.gov/pubmed/37242283 http://dx.doi.org/10.3390/nu15102400

Ejemplares similares

Milk protects against sarcopenic obesity due to increase in the genus Akkermansia in faeces of db/db mice
por: Okamura, Takuro, et al.
Publicado: (2023)

The effect of COVID-19 pandemic on the lifestyle and glycemic control in patients with type 1 diabetes: a retrospective cohort study
por: Hosomi, Yukako, et al.
Publicado: (2021)

Relationship between serum creatinine to cystatin C ratio and subclinical atherosclerosis in patients with type 2 diabetes
por: Hashimoto, Yoshitaka, et al.
Publicado: (2022)

Low circulating arachidonic acid is associated with macroalbuminuria in diabetic patients: a cross-sectional examination of the KAMOGAWA-DM cohort study
por: Okamura, Takuro, et al.
Publicado: (2021)

Effect of COVID-19 Pandemic on the Change in Skeletal Muscle Mass in Older Patients with Type 2 Diabetes: A Retrospective Cohort Study
por: Hasegawa, Yuka, et al.
Publicado: (2021)

Brazilian green propolis improves gut microbiota dysbiosis and protects against sarcopenic obesity
por: Okamura, Takuro, et al.
Publicado: (2022)

The Association of Salt Intake and Non-alcoholic Fatty Liver Disease in People With Type 2 Diabetes: A Cross-Sectional Study
por: Takahashi, Fuyuko, et al.
Publicado: (2022)

Characterization of Peripheral Blood TCR in Patients with Type 1 Diabetes Mellitus by BD Rhapsody(TM) VDJ CDR3 Assay
por: Okamura, Takuro, et al.
Publicado: (2022)

Eating Speed Is Associated with the Presence of Sarcopenia in Older Patients with Type 2 Diabetes: A Cross-Sectional Study of the KAMOGAWA-DM Cohort
por: Hashimoto, Yoshitaka, et al.
Publicado: (2022)

Sarcopenia Is Associated With a Risk of Mortality in People With Type 2 Diabetes Mellitus
por: Takahashi, Fuyuko, et al.
Publicado: (2021)

Effects of probiotic Bifidobacterium bifidum G9‐1 on the gastrointestinal symptoms of patients with type 2 diabetes mellitus treated with metformin: An open‐label, single‐arm, exploratory research trial
por: Hata, Shinnosuke, et al.
Publicado: (2021)

Gut Microbiota Changes by an SGLT2 Inhibitor, Luseogliflozin, Alters Metabolites Compared with Those in a Low Carbohydrate Diet in db/db Mice
por: Hata, Shinnosuke, et al.
Publicado: (2022)

Trans Fatty Acid Intake Induces Intestinal Inflammation and Impaired Glucose Tolerance
por: Okamura, Takuro, et al.
Publicado: (2021)

Reasons for Discontinuing Treatment with Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Diabetes in Real-World Settings: The KAMOGAWA-A Study
por: Saijo, Yuto, et al.
Publicado: (2023)

Impact of extracellular‐to‐intracellular fluid volume ratio on albuminuria in patients with type 2 diabetes: A cross‐sectional and longitudinal cohort study
por: Nakajima, Hanako, et al.
Publicado: (2020)

Habitual Miso (Fermented Soybean Paste) Consumption Is Associated with a Low Prevalence of Sarcopenia in Patients with Type 2 Diabetes: A Cross-Sectional Study
por: Takahashi, Fuyuko, et al.
Publicado: (2020)

Association between Geriatric Nutrition Risk Index and The Presence of Sarcopenia in People with Type 2 Diabetes Mellitus: A Cross-Sectional Study
por: Takahashi, Fuyuko, et al.
Publicado: (2021)

Habitual Miso (Fermented Soybean Paste) Consumption Is Associated with Glycemic Variability in Patients with Type 2 Diabetes: A Cross-Sectional Study
por: Takahashi, Fuyuko, et al.
Publicado: (2021)

Dental care and oral conditions are associated with the prevalence of sarcopenia in people with type 2 diabetes: a cross-sectional study
por: Takahashi, Fuyuko, et al.
Publicado: (2023)

Extracellular lipidome change by an SGLT2 inhibitor, luseogliflozin, contributes to prevent skeletal muscle atrophy in db/db mice
por: Bamba, Ryo, et al.
Publicado: (2021)

Dietary Fiber Intake Is Related to Skeletal Muscle Mass, Body Fat Mass, and Muscle-to-Fat Ratio Among People With Type 2 Diabetes: A Cross-Sectional Study
por: Takahashi, Fuyuko, et al.
Publicado: (2022)

Impact of Eating Speed on Muscle Mass in Older Patients With Type 2 Diabetes: A Prospective Study of KAMOGAWA–DM Cohort
por: Kobayashi, Genki, et al.
Publicado: (2022)

Inulin reduces visceral adipose tissue mass and improves glucose tolerance through altering gut metabolites
por: Nakajima, Hanako, et al.
Publicado: (2022)

Association of Estimated Salt and Miso Intake with the Prevalence of Obesity in People with Type 2 Diabetes: A Cross-Sectional Study
por: Takahashi, Fuyuko, et al.
Publicado: (2021)

Household Income Is Related to Dietary Fiber Intake and Dietary Acid Load in People with Type 2 Diabetes: A Cross-Sectional Study
por: Takahashi, Fuyuko, et al.
Publicado: (2022)

Japanese radio calisthenics prevents the reduction of skeletal muscle mass volume in people with type 2 diabetes
por: Kimura, Tomonori, et al.
Publicado: (2020)

Effect of probiotics, Bifidobacterium bifidum G9-1, on gastrointestinal symptoms in patients with type 2 diabetes mellitus: study protocol for open-label, single-arm, exploratory research trial (Big STAR study)
por: Hashimoto, Yoshitaka, et al.
Publicado: (2020)

Erythritol Ameliorates Small Intestinal Inflammation Induced by High-Fat Diets and Improves Glucose Tolerance
por: Kawano, Rena, et al.
Publicado: (2021)

Insulin dose reduction in dapagliflozin combination therapy for type 1 diabetes mellitus: the RISING-STAR study
por: Hamaguchi, Masahide, et al.
Publicado: (2022)

Let-7e-5p Regulates IGF2BP2, and Induces Muscle Atrophy
por: Okamura, Takuro, et al.
Publicado: (2021)

Vitamin Intake and Loss of Muscle Mass in Older People with Type 2 Diabetes: A Prospective Study of the KAMOGAWA-DM Cohort
por: Takahashi, Fuyuko, et al.
Publicado: (2021)

The Effects of Metformin on the Gut Microbiota of Patients with Type 2 Diabetes: A Two-Center, Quasi-Experimental Study
por: Nakajima, Hanako, et al.
Publicado: (2020)

Status of online diet management program users in Japan during the 2020 Coronavirus disease 2019 pandemic
por: Hamaguchi, Masahide, et al.
Publicado: (2021)

Relative low muscle mass and muscle strength is associated with the prevalence of metabolic syndrome in patients with type 2 diabetes
por: Takegami, Maya, et al.
Publicado: (2022)

Association between the frequency of toothbrushing and lifestyle in people with type 2 diabetes mellitus: at the baseline date of the Kamogawa-DM cohort study
por: Saijo, Yuto, et al.
Publicado: (2021)

Oral Exposure to Polystyrene Microplastics of Mice on a Normal or High-Fat Diet and Intestinal and Metabolic Outcomes
por: Okamura, Takuro, et al.
Publicado: (2023)

Usefulness of Exercise for Home Blood Pressure Control in People with Diabetes: A Study Protocol for a Crossover Randomized Controlled Trial
por: Iwai, Keiko, et al.
Publicado: (2020)

Usefulness of Aerobic Exercise for Home Blood Pressure Control in Patients with Diabetes: Randomized Crossover Trial
por: Iwai, Keiko, et al.
Publicado: (2022)

Habitual Dietary Intake Affects the Altered Pattern of Gut Microbiome by Acarbose in Patients with Type 2 Diabetes
por: Takewaki, Fumie, et al.
Publicado: (2021)

ILC2s Improve Glucose Metabolism Through the Control of Saturated Fatty Acid Absorption Within Visceral Fat
por: Okamura, Takuro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pd0ia429ki0f65a19tcr0jgfgi